retatrutide fat loss results The next big shift in obesity care may not be surgery — it may be a weekly shot. Retatrutide, an investigational triple-action medicine, showed 28.3% average body-weight over 80 weeks in 🚨 Retatrutide TRIUMPH-1 Phase 3

But without long-term safety data, semaglutide remains the more reliable option right now

Muniz is in dermatology private practice in So Paulo, Brazil

Most injectable GLP-1 medicationsincluding semaglutide (Wegovy) and tirzepatide (Zepbound)are given once a week

So this is a growing threat that I think needs to be monitored closely. If GLP-1s do become prohibited, athletes could theoretically apply for a therapeutic use exemption (TUE), which allows them to take a drug if it is treating a legitimate medical condition, and does not meaningfully enhance their performance

Cosmeceutical peptides

If you do not have heartburn yet, these can trigger the first episode